{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:43:36Z","timestamp":1761093816690,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.anai.2016.03.023","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T03:55:28Z","timestamp":1459914928000},"page":"584-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral blood mononuclear cell gene expression testing and the heterogeneity of T-cell\u2013mediated drug reaction with eosinophilia and systemic symptoms syndrome"],"prefix":"10.1016","volume":"116","author":[{"given":"Heather M.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore E.","family":"Kelbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faoud","family":"Ishmael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2016.03.023_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking","volume":"36","author":"Walsh","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.anai.2016.03.023_bib2","first-page":"122","article-title":"Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management","volume":"97","author":"Shiohara","year":"2012","journal-title":"Chem Immunol"},{"key":"10.1016\/j.anai.2016.03.023_bib3","first-page":"531","article-title":"Cytokine gene expression profiling to help identify a safe antibiotic in a patient with drug rash with eosinophilia and systemic symptoms","volume":"1","author":"Bhardwaj","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.03.023_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2016.03.023_bib5","first-page":"6","article-title":"Anti-inflammatory effects of methoxyphenolic compounds on human airway cells","volume":"9","author":"Houser","year":"2012","journal-title":"J\u00a0Inflamm"},{"key":"10.1016\/j.anai.2016.03.023_bib6","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jdv.13212","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases","volume":"29","author":"Skowron","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anai.2016.03.023_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction: results from the prospective RegiSCAR study","volume":"169","author":"Kaurdaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2016.03.023_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-7-72","article-title":"Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?","volume":"7","author":"Bouvresse","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.anai.2016.03.023_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2013.11.008","article-title":"Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms","volume":"2","author":"Galvao","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2016.03.023_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/imj.12462","article-title":"Vancomycin-associated drug reaction with eosinophilia and systemic symptoms and syndrome","volume":"44","author":"Young","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.anai.2016.03.023_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2500\/aap.2012.33.3498","article-title":"The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"33","author":"Blumenthal","year":"2012","journal-title":"Allergy Asthma Proc"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616300849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616300849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:14:42Z","timestamp":1761052482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120616300849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1081120616300849"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2016.03.023","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral blood mononuclear cell gene expression testing and the heterogeneity of T-cell\u2013mediated drug reaction with eosinophilia and systemic symptoms syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2016.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}